Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
    • Open access
    • COVID-19 submission information
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
    • Open access
    • COVID-19 submission information
  • Alerts
  • Podcasts
  • Subscriptions

Efficacy of fluticasone on cough

F. Hargreave, K. Parameswaran
European Respiratory Journal 2005 26: 181; DOI: 10.1183/09031936.05.00023205
F. Hargreave
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
K. Parameswaran
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

To the Editors:

In the original article by Ponsioen et al. 1, there is no mention of the predictive value of the type of airway inflammation that is associated with cough, or whether there was any benefit from inhaled corticosteroid treatment.

There is increasing evidence that eosinophilic airway inflammation, i.e. an eosinophilic bronchitis, which can be identified from spontaneous or induced sputum cell counts, predicts the benefit from corticosteroid treatment in chronic cough, asthma and chronic obstructive pulmonary disease and that a lack of eosinophilia indicates an absence of any benefit 2–6.

An eosinophilic bronchitis occurs in only 10–30% of patients referred to a specialist with an isolated chronic cough 7–9. Hence, in an unselected population of patients with cough, the majority of whom will not have eosinophilic bronchitis, the benefit from inhaled steroid treatment is likely to be small, as indicated in the study by Ponsioen et al. 1, or absent. Measurement of airway inflammation is necessary to interpret the results of treatment with anti-inflammatory medications.

    • © ERS Journals Ltd

    References

    1. ↵
      Ponsioen BP, Hop WCJ, Vermue NA, Dekhuijzen PNR, Bohnen AM. Efficacy of fluiticasone on cough: a randomised controlled trial. Eur Respir J 2005;145:147–152.
      OpenUrlCrossRef
    2. ↵
      Gibson PG, Dolovich J, Denburg J, Ramsdale EH, Hargreave FE. Chronic cough: eosinophilic bronchitis without asthma. Lancet 1989;17:1346–1348.
      OpenUrl
    3. Pavord ID, Brightling CE, Wolkman G, Wardlaw AJ. Non-eosinophilic corticosteroid unresponsive asthma. Lancet 1999;353:2213–2214.
      OpenUrlCrossRefPubMedWeb of Science
    4. Pizzichini E, Pizzichini MM, Gibson P, et al. Sputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive bronchitis. Am J Respir Crit Care Med 1998;158:1511–1517.
      OpenUrlCrossRefPubMedWeb of Science
    5. Brightling CE, Monteiro W, Ward R, et al. Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomized controlled trial. Lancet 2000;365:1480–1485.
      OpenUrl
    6. ↵
      Pizzichini MM, Pizzichini E, Parameswaran K, et al. Non-asthmatic chronic cough: no effect of treatment with an inhaled corticosteroid in patients without sputum eosinophilia. Can Respir J 1999;6:323–330.
      OpenUrlPubMed
    7. ↵
      Brightling CE, Ward R, Goh KL, Wardlaw AJ, Pavord ID. Eosinophilic bronchitis is an important cause of cough. Am J Respir Crit Care Med 1999;160:406–410.
      OpenUrlCrossRefPubMedWeb of Science
    8. Carney IK, Gibson PG, Murnee-Allen K, Saltos N, Olson LG, Hensley MJ. A systematic evaluation of mechanisms in chronic cough. Am J Respir Crit Care Med 1997;156:211–216.
      OpenUrlPubMedWeb of Science
    9. ↵
      Ayik SO, Basoglu OK, Erdinc M, Bor S, Veral A, Bilgen A. Eosinophilic bronchitis as a cause of chronic cough. Respir Med 2003;97:695–701.
      OpenUrlCrossRefPubMedWeb of Science
    PreviousNext
    Back to top
    View this article with LENS
    Vol 26 Issue 1 Table of Contents
    • Table of Contents
    • Index by author
    Email

    Thank you for your interest in spreading the word on European Respiratory Society .

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Efficacy of fluticasone on cough
    (Your Name) has sent you a message from European Respiratory Society
    (Your Name) thought you would like to see the European Respiratory Society web site.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Print
    Alerts
    Sign In to Email Alerts with your Email Address
    Citation Tools
    Efficacy of fluticasone on cough
    F. Hargreave, K. Parameswaran
    European Respiratory Journal Jul 2005, 26 (1) 181; DOI: 10.1183/09031936.05.00023205

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero

    Share
    Efficacy of fluticasone on cough
    F. Hargreave, K. Parameswaran
    European Respiratory Journal Jul 2005, 26 (1) 181; DOI: 10.1183/09031936.05.00023205
    del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
    Full Text (PDF)

    Jump To

    • Article
      • References
    • Info & Metrics
    • PDF
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    More in this TOC Section

    • Prevalence of pulmonary embolism on hospital admission in COVID-19 patients: Is there a role for pre-test probability scores and home treatment?
    • Asthma admissions during the COVID-19 pandemic
    • Defining optimal fluoroquinolone exposure against M. tuberculosis
    Show more Correspondence

    Related Articles

    Navigate

    • Home
    • Current issue
    • Archive

    About the ERJ

    • Journal information
    • Editorial board
    • Reviewers
    • CME
    • Press
    • Permissions and reprints
    • Advertising

    The European Respiratory Society

    • Society home
    • myERS
    • Privacy policy
    • Accessibility

    ERS publications

    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS books online
    • ERS Bookshop

    Help

    • Feedback

    For authors

    • Instructions for authors
    • Submit a manuscript
    • ERS author centre

    For readers

    • Alerts
    • Subjects
    • Podcasts
    • RSS

    Subscriptions

    • Accessing the ERS publications

    Contact us

    European Respiratory Society
    442 Glossop Road
    Sheffield S10 2PX
    United Kingdom
    Tel: +44 114 2672860
    Email: journals@ersnet.org

    ISSN

    Print ISSN:  0903-1936
    Online ISSN: 1399-3003

    Copyright © 2021 by the European Respiratory Society